Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Elongin C pseudogene 34 (ELOCP34)
- Target
- ELOCP34
- Molecular classification
- Other (Processed pseudogene/Retrogene)
01
Overview
Elongin C pseudogene 34 (ELOCP34), also known as TCEB1P34, is a processed pseudogene located on chromosome 8. It is a retrocopy (retrogene) derived from the parental ELOC (elongin C) gene. Unlike the protein-coding ELOC gene, which acts as a component of the RNA polymerase II elongation complex and plays regulatory roles in transcription, ELOCP34 does not encode a functional protein, nor does it play a known role in biology or human disease. ELOCP34 shares sequence similarity with ELOC but lacks protein-coding capacity and is not a therapeutic target.
- Other names
- TCEB1P34transcription elongation factor B (SIII), polypeptide 1 pseudogene 34transcription elongation factor B subunit 1 pseudogene 34
02
Mechanism of action
None (not a therapeutic target)
03
Biological functions
None (pseudogenes generally do not encode functional protein products)
04
Disease associations
None (as a pseudogene, ELOCP34 does not have demonstrated roles in disease). Disease associations for the functional ELOC gene should not be attributed to ELOCP34.
05
Safety considerations
None (does not encode a functional product; not a druggable target)
06
Interacting drugs
None (no known drugs interact with ELOCP34 as it is non-functional)
07
Biomarkers
None known for pseudogene ELOCP34
Beyond the preview
Go deeper on Elongin C pseudogene 34 (ELOCP34).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Elongin C pseudogene 34 (ELOCP34).